FindTrial
Sign In

EMPIRICAL AND TARGETED TREATMENT FOR TAENIA SOLIUM SOLITARIA (PERU)

EMPIRICAL AND TARGETED TREATMENT FOR TAENIA SOLIUM SOLITARIA (PERU)

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-082-13
Enrollment
2000
Registered
2014-02-27
Start date
2014-01-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Niclosamide 500 mg, presentation tablets, single dose according to weight: 11-34 kg (02 tablets or 1 gram) 35-49 kilos (03 tablets) more than 50 kilos (04 tablets) If we find a positive Pi

Sponsors

UNIVERSIDAD PERUANA CAYETANO HEREDIA,
Lead Sponsor

Eligibility

Age
2 Years to 100 Years

Inclusion criteria

Inclusion criteria: All community residents older than 2 years of age or weighing more than 11 kg.

Exclusion criteria

Exclusion criteria: Inability to provide informed consent.

Countries

Peru

Contacts

Public ContactHector Hugo Garcia

UNIVERSIDAD PERUANA CAYETANO HEREDIA

hgarcia@jhsph.edu3287360

Outcome results

None listed

Source: REPEC (via WHO ICTRP)